Investigating infant deaths. by Ward Platt MP
Where next? Identifying more breast cancers at
earlier stages with “good prognosis” can make
decisions about appropriate adjuvant treatment more
complex, bringing a real risk of relative overtreatment
of some women. This could be particularly important
in lymph node negative and steroid hormone receptor
positive breast cancer. Better understanding of the
gene expression signatures of breast cancers may lead
to new classifications that may have both prognostic
and predictive information.11 A trial is already
investigating this approach in premenopausal women,
comparing selection by microarray signature against
conventional criteria.12
Finally, while the work discussed here highlights
the improvements in survival from breast cancer
attributable to systemic therapy and diagnosis of small,
node negative tumours, neither approach affects
incidence. The diagnosis of breast cancer, even with a
supposedly good prognosis, can be devastating, and we
should not lose sight of primary prevention as a real
goal.
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Investigating infant deaths
The protocol suggested by the Kennedy report is good, but will it work?
There is now another “Kennedy report” forpaediatricians to consider.1 This time the chairwas Baroness Helena Kennedy QC, the work-
ing group was set up by the royal colleges of Paediat-
rics and Child Health and of Pathology, and the
subject was the investigation of sudden unexpected
deaths in infants (SUDI). The report recommends a
systematic and evidence based protocol for the
history, examination, investigation, autopsy, death
scene investigation, and subsequent multiprofessional
meeting in relation to each death.1 It also recommends
that this should be compulsory, although it doesn’t say
how that might be enforced. But will it have the
desired effect?
The background is several recent high profile cases
in the United Kingdom of mothers accused of killing
their infants: the quashing of the convictions of Sally
Clarke and Angela Cannings; the acquittal of Trupti
Patel; and cases such as that of Maxine Robinson, who
originally protested her innocence of the deaths of the
two children she was convicted of murdering but who
this year admitted their murders, together with the
murder of her first child.2 The death of this infant, who
died aged 9 months, was originally labelled as a cot
death. These cases highlight the widespread problem
of the inadequate investigation of infant deaths.
Improvements should work both ways: a greater
chance of avoiding criminal proceedings for innocent
parents (the majority) but also a higher chance of iden-
tifying homicide.Whether the criminal justice system is
an appropriate place to deal with infant murder is
debatable, but the need for a more coherent and
evidence based approach to investigating infant deaths
is hard to dispute.
Much of the UK evidence base for an improved
and comprehensive approach has come from the large
scale case-control study of sudden unexpected deaths
in infancy conducted by the Confidential Enquiry into
Stillbirths and Deaths in Infancy (CESDI) in the early
1990s.3 Helena Kennedy’s recommendations bear a
close resemblance to those in the CESDI-SUDI report
and are explicitly based on the practices that are
routine in Bristol and the south west region.
So will the protocol recommended by Baroness
Kennedy make a difference? Here we are on uncertain
ground. The mere existence of a protocol is not a guar-
antee that it will be followed, however much it might be
“compulsory”; the history of protocolology is one of
worthy aspirations that largely fail to change practice
in the real,messy world.4 5 This issue includes data from
Sussex that indicate that the messy world has once
again triumphed (p 227) 6. Even in the management of
sudden unexpected deaths in infants, trying to change
practice needs a whole lot more than a protocol, how-
ever much the protocol has been agreed among the
different agencies and disciplines.
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Paediatricians will view some of the recommenda-
tions as aspirational rather than immediately practical.
How many paediatricians will feel able to commit to
making home visits, which may last several hours, at
very short notice to bereaved families, or participate in
death scene investigations? Given the potential for
child protection issues to arise, and the current
reluctance of paediatricians to take on child protection
work, is it realistic to expect paediatricians in general to
be enthusiastic about this task? Taking a gold standard,
research supported system in a part of the country
served by internationally renowned enthusiasts and
trying to replicate it in hectic paediatric services
elsewhere may prove overoptimistic.
Yet much of the protocol is not about home visits
or the detailed role of paediatricians. It is about the
comprehensive gathering of information on first
contact with health services, and the systematic record-
ing of the data. It is about ensuring that pathologists
and coroners recognise that making a positive diagno-
sis and using appropriate investigations and histology
is at least as important as making a statement about the
likelihood of foul play on macroscopic examination
alone. It is about convening a multidisciplinary
meeting to pool all the information and determine the
medical view of the cause of death. We should not lose
sight of the potential of this protocol for improving the
investigation of unexpected infant deaths by getting
too focused on the role of paediatricians in the imme-
diate aftermath of the death.
What might drive improvements in the manage-
ment of sudden unexpected infant deaths if protocols
by themselves are not enough? Audit could be a pow-
erful tool, especially if the anonymised and aggregated
results were published. Just as the SUDI study was
performed under the auspices of CESDI, perhaps its
successor, the confidential enquiry into maternal and
child health (CEMACH), should undertake this
function in the future. Confidential inquiry would be
an appropriate method to examine the processes by
which each death was investigated, rating actual
practice against the standards set out in Baroness
Kennedy’s recommendations. Feedback could be
relatively swift; could embrace coroners, police, social
services, and health services; and could operate within
the areas served by each confidential inquiry office.
Under these circumstances, each death would yield
learning points, could engage paediatricians, and
should contribute to our evolving understanding of
sudden infant deaths.
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Managing faecal incontinence
Simple measures in primary care are often effective
Faecal incontinence is a major problem. A recentsystematic review of the literature shows a preva-lence of 11-15% in the community.1 These
figures have to be interpreted with caution because the
relevant studies are hampered by possible under-
reporting and, more importantly, by a lack of a consen-
sus definition. Incontinence of flatus, liquid stool, or
solid stool that has an impact on quality of life is a
practical definition,2 and here we summarise the man-
agement of this heterogeneous condition mostly from
a primary care perspective but including possible
surgical interventions.
Faecal incontinence has many causes and varies in
severity from minor faecal soiling to frank inconti-
nence of solid stool. When a patient presents with this
symptom we need to establish the degree of debility
and obtain an obstetric history.3 Inspection of the anal
canal and digital rectal examination is essential. Anal
skin tags associated with haemorrhoids can hinder
adequate toilet, and poor anal tone implies a defect in
the anal sphincter. Diminished sensation and lack of
anal contraction or “winking” indicate an underlying
neurological condition.
Disruption of the anal sphincter results most com-
monly from vaginal delivery, occurs in 30% of parous
women, and is associated with symptomatic inconti-
nence in about 80% of cases.4 Injury to the pudendal
nerve often accompanies injury to the anal sphincter
owing to obstetric causes and contributes to
incontinence, as does pre-existing irritable bowel syn-
drome.5 6 Other causes of acquired faecal inconti-
nence include anal trauma, anal surgery, a wide range
of neurological and psychiatric disorders, and rectal
prolapse.
Although damage to the anal sphincter must
always be considered, most patients do not have a seri-
ous physical disorder requiring intensive investigation
and surgery. Those with minor soiling or difficulty in
cleansing can be helped greatly by simple reassurance
and advice on washing with a sponge after defecation.
Some will also benefit from insertion of a glycerine
suppository immediately after defecation and reten-
tion for about 20 minutes, as this will facilitate further
rectal emptying and ameliorate subsequent soiling. We
also need to recognise that causes of loose stool—such
as inflammatory bowel disease, malabsorption, overuse
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